The US Food and Drug Administration asked five manufacturers to recall their extended-release formulations of the diabetes drug metformin on May 28, 2020. Corbis via Getty Images
The US Food and Drug Administration asked five manufacturers to recall their extended-release formulations of the diabetes drug metformin on May 28, 2020. Corbis via Getty Images

US advises recall of diabetes drug metformin over high levels of suspected carcinogen